Edward J. Benz JR - 23 Jun 2021 Form 4 Insider Report for Deciphera Pharmaceuticals, Inc. (DCPH)

Role
Director
Signature
/s/ Thomas P. Kelly, Attorney-in-Fact
Issuer symbol
DCPH
Transactions as of
23 Jun 2021
Net transactions value
$0
Form type
4
Filing time
25 Jun 2021, 16:00:26 UTC
Next filing
26 Jul 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DCPH Stock Option (Right to Buy) Award $0 +12,000 $0.000000 12,000 23 Jun 2021 Common Stock 12,000 $35.86 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option was issued pursuant to the Issuer's 2017 Stock Option and Incentive Plan. The option shall vest in full on June 23, 2022, subject to continued service through such date.